No Data
No Data
Aligos Therapeutics Appoints David Perry as Vice President of Business Development
Aligos Therapeutics to Present at Investor Conferences in October
Express News | Aligos Therapeutics Strengthens Senior Leadership Team With the Appointment of Hardean Achneck, Md as Chief Medical Officer
Press Release: Aligos Therapeutics Strengthens Senior Leadership Team With the Appointment of Hardean Achneck, MD as Chief Medical Officer
Aligos Therapeutics Analyst Ratings
H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $75
No Data
No Data